• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

Primary Care Expansion NEURO





Yikes.. I thought that was an industry standard. How do they get people to work here?
Nothing at ITCI is industry standard. We were in the field two months after the Covid pandemic started and they PIP'd people who could get access to their prescribers. It took four years to finally offer a holiday shut down at Christmas. They didn't conduct an employee survey until four years post launch. No communication. No transparency at all. It's been over a year since Genoa stopped reporting and they still haven't figured that out.